Exicure Announces Plans for New Clinical Trial in Acute Myeloid Leukemia (AML)
Exicure Announces Plans for New Clinical Trial in Acute Myeloid Leukemia (AML) Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company focused on developing innovative therapeutics targeting diseases with high unmet…
Arcturus Gets FDA Fast Track for H5N1 mRNA Vaccine
Arcturus Therapeutics Secures FDA Fast Track Designation for ARCT-2304, a Next-Generation sa-mRNA Vaccine Targeting Pandemic Influenza A (H5N1) In a significant milestone for mRNA vaccine innovation, Arcturus Therapeutics Holdings Inc.…
Signios Bio Debuts with AI-Powered Multiomics Platform for Precision Medicine and Drug Discovery
Signios Biosciences Unveils Rebrand and Expands Vision as a Leading Multiomics and AI Bioinformatics Innovator in Precision Medicine In a bold step forward reflecting its evolution and expanded capabilities, Signios…
Avanzanite Bioscience Names Sotiris Botozis as Managing Director for Southern Europe
Avanzanite Bioscience Appoints Sotiris Botozis as Managing Director for Southern Europe Amid Strategic Expansion and Unprecedented Growth Avanzanite Bioscience BV, a rapidly growing player in the European life sciences and…
FDA Grants Full Approval to VITRAKVI for NTRK Fusion-Positive Tumors
FDA Grants Full Approval to Bayer’s VITRAKVI® (Larotrectinib), a Landmark TRK Inhibitor for Patients with NTRK Fusion-Positive Solid Tumors In a milestone for precision oncology, Bayer announced today that the…
Biologic Therapy Boosts Pregnancy Outcomes in High-Risk APS Patients
Biologic Therapy Boosts Pregnancy Outcomes in High-Risk APS Patients Landmark Clinical Trial Finds Certolizumab Significantly Improves Pregnancy Outcomes in Women with Antiphospholipid Syndrome In a groundbreaking advancement for maternal-fetal medicine…
Survey: Americans Shocked by Rx Costs, Few Talk to Pharmacists
Survey: Americans Shocked by Rx Costs, Few Talk to Pharmacists A recent nationwide survey conducted by Lumicera Health Services— the specialty pharmacy arm of Navitus Health Solutions—has unveiled a paradox…
Two Major Trials Identify Effective Antibiotic Selection Method for Hospitalized Infection Patients
Two Major Trials Identify Effective Antibiotic Selection Method for Hospitalized Infection Patients In a significant advancement for infectious disease care and antibiotic stewardship, two large-scale clinical trials funded by the…
Amylyx Begins Dosing in Phase 1 LUMINA Trial of AMX0114 for ALS
Amylyx Begins Dosing in Phase 1 LUMINA Trial of AMX0114 for ALS Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a biopharmaceutical company dedicated to the development of innovative treatments for neurodegenerative diseases,…
Textron Aviation Opens Second Plane Healthy Wellness Center & Pharmacy in Wichita to Enhance Employee Healthcare Access
Textron Aviation Opens Second Plane Healthy Wellness Center & Pharmacy in Wichita to Enhance Employee Healthcare Access Textron Aviation Inc., a renowned aircraft manufacturer and a subsidiary of Textron Inc.…
California Advocates Urge Greater Access to Plasma-Derived Medicines
California Advocates Urge Greater Access to Plasma-Derived Medicines In a compelling call to action, the California Rare Disease Access Coalition, Hemophilia Council of California, and the Plasma Protein Therapeutics Association…
NexThera Begins U.S. Trial with First Patient Dosed for Wet AMD Eye Drop NT-101
NexThera Begins U.S. Trial with First Patient Dosed for Wet AMD Eye Drop NT-101 NexThera Co., Ltd., a biotechnology company at the forefront of ophthalmic innovation, announced a pivotal milestone…